CD274 and cancer: However, in head-to-head comparison between studies in which most cancers had a high PD-L1 expression vs. those with a minority where PD-L1 positive, our analysis would indicate that using PD-L1 as a ICPI treatment biomarker was of deleterious effect, although this did not reach significance.